Maria Hadjidemetriou1. Show Affiliations » 1. New York City, New York, USA.
Abstract
Entities: Disease
Mesh： See more » Attitude of Health PersonnelAttitude to HealthChelation Therapy/adverse effectsChelation Therapy/psychologyCyprus/ethnologyDeferiproneDeferoxamine/adverse effectsDeferoxamine/therapeutic useDisease ManagementDrug ApprovalFemaleHistory, 20th CenturyHistory, 21st CenturyHumansIron Chelating Agents/adverse effectsIron Chelating Agents/therapeutic useLife StyleParent-Child RelationsPower, PsychologicalPyridones/therapeutic useSelf CareSocial StigmaSocial SupportSplenectomyThalassemia/complicationsThalassemia/ethnologyThalassemia/psychologyThalassemia/therapyUnited StatesUnited States Food and Drug Administration
Substances： See more » Iron Chelating AgentsPyridonesDeferiproneDeferoxamine
Year: 2017 PMID： 28370242 DOI： 10.1002/ajh.24744
Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047